Profile data is unavailable for this security.
About the company
Jiangsu Lianhuan Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, production and sales of chemical medicines. The Company's products are mainly applied as urinary system medicines, antihistamines and cardiovascular medicines. The Company's products include Epristeride Tablets, Ebastine Tablets, Felodipine Tablets, Felodipine Sustained Release Capsules, Simvastatin Tablets, Lumbrokinase Capsulesand and Balofloxacin Tablets. The Company distributes its products within domestic market and to overseas markets.
- Revenue in CNY (TTM)2.25bn
- Net income in CNY136.43m
- Incorporated2000
- Employees1.30k
- LocationJiangsu Lianhuan Pharmaceutical Co LtdNo.21, Wenfeng RoadYANGZHOU 225127ChinaCHN
- Phone+86 51 487813082
- Fax+86 51 487815079
- Websitehttp://www.lhpharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Kai Kai Industrial Co Ltd | 959.84m | 52.77m | 1.97bn | 492.00 | 48.40 | 4.13 | -- | 2.05 | 0.2172 | 0.2172 | 3.95 | 2.55 | 0.7819 | 10.68 | 3.50 | 1,950,902.00 | 4.49 | 2.39 | 6.98 | 3.53 | 18.63 | 23.54 | 5.74 | 3.20 | 1.28 | -- | 0.0355 | 26.33 | 3.46 | 1.06 | -1.57 | 2.21 | 34.01 | 1.72 |
| Beihai Gofar Chuanshan Biological Co Ltd | 355.15m | -92.02m | 2.46bn | 463.00 | -- | 2.87 | -- | 6.92 | -0.1755 | -0.1755 | 0.6775 | 1.63 | 0.3258 | 3.17 | 1.49 | 767,059.10 | -8.32 | -0.517 | -9.99 | -0.6208 | 22.89 | 24.59 | -25.54 | -1.44 | 2.60 | -63.64 | 0.0336 | -- | -19.69 | 10.46 | -336.10 | -- | -17.59 | -- |
| Jiangsu Lianhuan Pharmaceutical Co. Ltd | 2.25bn | 136.43m | 2.77bn | 1.30k | 20.33 | 1.99 | -- | 1.23 | 0.4767 | 0.4767 | 7.86 | 4.86 | 0.813 | 3.96 | 4.60 | 1,736,789.00 | 5.54 | 5.93 | 10.82 | 11.25 | 47.56 | 53.26 | 6.81 | 7.82 | 0.8523 | 7.35 | 0.3362 | 30.64 | 11.20 | 16.36 | -4.50 | 12.91 | 9.35 | 13.97 |
| Shanghai New World Co Ltd | 1.15bn | 33.59m | 4.08bn | 1.20k | 121.34 | 0.9695 | -- | 3.56 | 0.0519 | 0.0519 | 1.77 | 6.50 | 0.2026 | 4.62 | 7.42 | 951,798.10 | 0.5858 | 0.5242 | 0.78 | 0.7249 | 38.56 | 33.70 | 2.89 | 2.71 | 1.52 | -- | 0.1222 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
Data as of Apr 18 2024. Currency figures normalised to Jiangsu Lianhuan Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.42%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Gfund Management Co., Ltd.as of 30 Jun 2023 | 852.70k | 0.30% |
| CITIC-Prudential Fund Management Co., Ltd.as of 30 Jun 2023 | 123.30k | 0.04% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 70.30k | 0.03% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2023 | 47.40k | 0.02% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 30.40k | 0.01% |
| Sealand Securities Co., Ltd. (Investment Management)as of 30 Jun 2023 | 26.30k | 0.01% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2023 | 18.90k | 0.01% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2023 | 13.40k | 0.01% |
| Dongxing Asset Management Co. Ltd.as of 30 Jun 2023 | 4.70k | 0.00% |
More ▼
Data from 30 Jun 2023 - 02 May 2024Source: FactSet Research Systems Inc.
